Abstract
A 55-year old male, diagnosed as Ph1 (+) ALL in July 1992, subsequently achieved complete remission. However, he was admitted again in November 1993 because of relapse. Although blasts in bone marrow decreased following chemotherapy and G-CSF administration, thromocytopenia remained, and he needed platelet transfusions every other day. After he began receiving M-CSF, the platelet count increased and platelet transfusions became unnecessary. M-CSF may be useful for thrombocytopenia after chemotherapy in Ph1 (+) ALL.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Granulocyte Colony-Stimulating Factor / adverse effects*
-
Granulocyte Colony-Stimulating Factor / therapeutic use
-
Humans
-
Macrophage Colony-Stimulating Factor / therapeutic use*
-
Male
-
Middle Aged
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
-
Recurrence
-
Thrombocytopenia / etiology*
-
Thrombocytopenia / therapy*
Substances
-
Granulocyte Colony-Stimulating Factor
-
Macrophage Colony-Stimulating Factor